Skip to main content
SpringerLink
Log in

Radiotherapy of the Pancreas: State of the Art in 2012

  • Conference paper
  • First Online:
Early Gastrointestinal Cancers

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 196))

Abstract

Pancreatic adenocarcinoma (PA) is a rare tumor; it represents 2–3 % of all new cancer cases in Europe and USA, and 95 % of malignant pancreatic tumors (Parkin et al. 2001). PA is an aggressive disease with a poor prognosis, one-year survival rate of 25 % and a five-year survival rate of less than 5 % (Evans et al. 2001). PA is among the top five causes of cancer-related death in adults in most industrialized countries, with over 70,000 deaths per year in Europe and the USA (Fernandez et al. 1994; Bramhall et al. 1995; Bramhall et al. 1998; Parkin et al. 2001; Jemal et al. 2002).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alfieri S, Morganti AG, Di Giorgio A et al (2001) Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer. Arch Surg 136:343–347

    Article  PubMed  CAS  Google Scholar 

  • Baumel H, Huguier M, Manderscheid JC et al (1994) Results of resection for cancer of the exocrine pancreas: a study from the French association of surgery. Br J Surg 81:102–110

    Article  PubMed  CAS  Google Scholar 

  • Ben-Josef E, Griffith K, Francis IR et al (2009) Phase I radiation dose –escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDRG) for unresecatable pancreatic cancer. J Clin Oncol 27:a4602

    Article  Google Scholar 

  • Ben-Josef E, Shields AF, Vaishampayan U et al (2004) Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys 59:454–459

    Article  PubMed  CAS  Google Scholar 

  • Bichenbach KA, Gonen M,Tang LH et al. (2011) Down staging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Annal surgical oncol. doi: 10.124/s10434-011-2156-7

    Google Scholar 

  • Bouchard M, Amos RA, Briere TM et al (2009) Dose escalation with proton or photon radiation treatment for pancreatic cancer. Radiother Oncol 92:238–243

    Article  PubMed  Google Scholar 

  • Bramhall SR, Allum WH, Jones AG et al (1995) Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111–115

    Article  PubMed  CAS  Google Scholar 

  • Bramhall SR, Dunn J, Neoptolemos JP et al. (1998) Epidemiology of pancreatic cancer. In: Carr-Locke (ed); the pancreas, Blackwell Scientific, Boston pp 889–906

    Google Scholar 

  • Chang BW, Saif MW (2008) Stereotactic body radiation therapy (SBRT) in Pancreatic Cancer: is it ready for prime time. JOP. J Pancreas (Online) 9(6):676–682

    Google Scholar 

  • Ceha HM, Van Tienhoven G, Gouma DJ et al (2000) Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 89:2222–2229

    Article  PubMed  CAS  Google Scholar 

  • Chauffert B, Mornex F, Bonnetain F et al (2008) Phase III trial comparing initial chemoradiotherapy (intermittent cisplatine and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: a FFCD-SFRO study. Ann Oncol 19:1592–1599

    Article  PubMed  CAS  Google Scholar 

  • Crane CH, Antolak JA, Rosen II et al (2001) Phase I study of concomitant gemcitabine and IMRT for patient with unresecable adenocarcinoma of the pancreatic head. Int J Gastrointest cancer 30:123–132

    Article  PubMed  CAS  Google Scholar 

  • Chang DT, Schellenberg D, Shen J et al. (2008) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009. doi: 10.1002/cncr.24059

  • Ducreux M, Boige V, Goéré D et al (2007) Pancreatic cancer: from pathogenesis to cure. Best Pract Res Clin Gastroenterol 21(6):997–1014

    Article  PubMed  CAS  Google Scholar 

  • Edis AJ, Kiernan PD, Taylor WF (1980) Attempted curative resection of ductal carcinoma of the pancreas. Review of Mayo clinic experience, 1951–1975. Mayo Clin Proc 55:531–536

    PubMed  CAS  Google Scholar 

  • Evans DB, Abbruzzese JL, Willett CG et al. (2001) Cancer of the pancreas. Principles and practice of oncology. In: Hellman S, Rosenberg SA (eds), Lippincott Williams and Wilkins, Philadelphia 1126–1161

    Google Scholar 

  • Evans DB, Varadhachary GR, Crane CH et al (2008) Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26:3496–3502

    Article  PubMed  CAS  Google Scholar 

  • Fernandez E, La Vecchia C, Porta M et al (1994) Trends in pancreatic cancer mortality in Europe, 1955–1989. Int J Cancer 57:786–792

    Article  PubMed  CAS  Google Scholar 

  • Gillen S, Schuster T, Meyer Zum Büschenfelde C et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7(4): e1000267

    Google Scholar 

  • Gillmore R, Laurence V, Raouf S et al (2010) Chemoradiotherapy with or without induction chemotherapy for locally advanced pancreatic cancer: a UK multi-institutional experience. Clin Oncol (R Coll Radiol) 22(7): 564–569

    Article  CAS  Google Scholar 

  • Gorski DH, Beckett MA, Jaskowiak NT et al (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59:3374–3378

    PubMed  CAS  Google Scholar 

  • Griffin JF, Smalley SR, Jewell W et al (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56–61

    Article  PubMed  CAS  Google Scholar 

  • Haller DG (2003) Chemotherapy for advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 56:16–23

    Article  PubMed  CAS  Google Scholar 

  • Hidalgo M (2010) Pancreatic cancer. N E J Med 362:1605–1617

    Article  CAS  Google Scholar 

  • Hoffman JP, Lipsitz S, Pisansky T et al (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an eastern cooperative oncology group study. J Clin Oncol 16:317–323

    PubMed  CAS  Google Scholar 

  • Hoffman JP, Weese JL, Solin LJ et al (1995) A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 169:71–77

    Article  PubMed  CAS  Google Scholar 

  • Hsu CC, Herman JM, Corsini MM et al (2010) Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins hospital-mayo clinic collaborative study. Ann Surg Oncol 17:981–990

    Article  PubMed  Google Scholar 

  • Huang J, M.robertson J, Margolis J and al (2011) Long-term results of full-dose gemcitabine with radiation therapy compared TO 5-FLUOROURACIL radiation therapy for locally advanced pancreas cancer. doi:10.1016/j.radonc.2011.05.038

  • Janes RH, Niederhuber JE, Chmiel JS et al (1996) National patterns of care for pancreatic cancer. Results of a survey by the commission on cancer. Ann Surg 223:261–272

    Article  PubMed  Google Scholar 

  • Jemal A, Thomas A, Murray T et al (2002) Cancer statistics. CA Cancer J Clin 52:23–47

    Article  PubMed  Google Scholar 

  • Johnstone PA, Sindelar WF (1993) Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys 27:831–834

    Article  PubMed  CAS  Google Scholar 

  • Johung K, Saif MW, Chang BW (2012) Treatment of locallyadvanced pancreatic cancer: the role of radiation therapy. Int J Radiat Oncol Biol Phys 82(2):508–518

    Article  PubMed  Google Scholar 

  • Kindler HL, Niedzwiecki D, Hollis D, et al (2007) A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): a preliminary analysis of cancer and leukemia group B (CALGB) 80303. In Proceedings of the GI ASCO symposium, abstract no 108. http://www.asco.org/ASCOv2/Meetings/Abstracts?vmview=abst_detail_view&abstractID=10557&confID=45

  • Klinkenbijl HL, Jeekel J, Sahmoud T et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776–782

    Article  PubMed  CAS  Google Scholar 

  • Krempien R, Munter MW, Timke C et al. (2007) Cetuximab in combination with intensity modulated radiotherapy (IMRT) and gemcitabine for patients with locally advanced pancreatic cancer: a prospective phase II trial [PARC-Study ISRCTN56652283]. Proc Am Soc Clin Oncol, 25:4573

    Google Scholar 

  • Laurence JM, Tran PD, Morarji K, Eslick GD, Lam VW, Sandroussi C (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg 15(11):2059–2069. doi:10.1007/s11605-011-1659

    Article  PubMed  Google Scholar 

  • Le Scodan R, Mornex F, Girard N et al (2009) Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann Oncol 20(8): 1387–1396

    Article  PubMed  CAS  Google Scholar 

  • Lee JH, Whittington R, Williams NN et al (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 47:945–953

    Article  PubMed  CAS  Google Scholar 

  • Mahadevan A, Jain S, Goldstein M et al (2010) Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiation Oncology Biol Phys 78(3):735–742

    Article  Google Scholar 

  • Manabe T, Ohshio G, Baba N et al (1989) Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64:1132–1137

    Article  PubMed  CAS  Google Scholar 

  • Mehta VK, Fisher GA, Ford JM et al (2000) Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys 48:1483–1487

    Article  PubMed  CAS  Google Scholar 

  • Milano MT, Chmura SJ, Garofalo MC et al (2004) Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 59:445–453

    Article  PubMed  Google Scholar 

  • Moertel CG, Childs DS, Reitemeier RJ et al (1969) Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865–867

    Article  PubMed  CAS  Google Scholar 

  • Moertel CG, Frytak S, Hahn RG et al (1981) Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 Rads) radiation alone, moderate dose radiation (4000 Rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Gastrointest Tumor Study Group Cancer 48:1705–1710

    CAS  Google Scholar 

  • Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the national cancer institute of canada clinical trials group. J Clin Oncol 25:1960–1966

    Article  PubMed  CAS  Google Scholar 

  • Mori S, Hara R, Yanagi T et al (2009) Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumours using a 256 multi-slice CT scanner. Radiother Oncol 92:231–237

    Article  PubMed  Google Scholar 

  • Mornex F, Girard N, Scoazec JY et al (2006) Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 phase II trial. Int J Radiat Oncol Biol Phys 65(5): 1471–1478

    Article  PubMed  CAS  Google Scholar 

  • Neoptolemos JP, Stocken DD, Friess H (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

    Article  PubMed  CAS  Google Scholar 

  • Pan T, Lee TY, Rietzel E et al (2004) 4D-CT imaging of a volume influenced by Respiratory motion on multi-slice CT. Med Phys 31:333–340

    Article  PubMed  Google Scholar 

  • Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl. 8):S4–S66

    Article  PubMed  Google Scholar 

  • Philip PA, Benedetti C, Fenoglio-Preiser Cet al (2007). Phase III study of gemcitabine (G) plus cetuximab (C) versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (PC): SWOG S025 study. Proc Am Soc Clin Oncol, 25:[LBA4509]

    Google Scholar 

  • Rietzel E, Chen GT, Choi NC et al (2005) Four-dimensional image-based treatment planning target volume segmentation and dose calculation in the presence of respiratory motion. Int J Radiat Oncol Biol Phys 61:535–555

    Article  Google Scholar 

  • Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, et al. (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299:1019–1026. [PMID18319412]

    Google Scholar 

  • Roy R, Maraveyas A (2010) Chemoradiation in pancreatic adenocarcinoma: a literature review. Oncologist 15:259–269

    Article  PubMed  CAS  Google Scholar 

  • Schellenberg D, Kim J, Christman-Skieller C et al (2011) Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 81(1):181–188

    Article  PubMed  Google Scholar 

  • Sohn TA, Lillemoe KD, Cameron JL et al (1999) Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome. Ann Surg 229:393–400

    Article  PubMed  CAS  Google Scholar 

  • Stessin AM, Meyer JE, Sherr DL (2008) Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. Int J Radiat Oncol Biol Phys 72(4): 1128–1133

    Google Scholar 

  • Sultana A, Tudur Smith C, Cunningham D et al (2007) Systematic review, including meta-analyses, on the management of locally advanced pancreaticcancer using radiation/combined modality therapy. Br J Cancer 96(8):1183–1190

    Google Scholar 

  • Talamonti MS, Catalano PJ, Vaughn DJ et al (2000) Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol 18:3384–3389

    PubMed  CAS  Google Scholar 

  • Van Laethem JL, Demols A, Gay F et al (2003) Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study. Int J Radiat Oncol Biol Phys 56:974–980

    Article  PubMed  Google Scholar 

  • Van Laethem JL, Hammel P, Mornex F, Azria D, et al. (2010) Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study. J Clin Oncol 2010. doi: 10.1200/JCO.2010.30.3446

  • Van Tienhoven JL, Gouma J, Richel D (2011) Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma. Ther Adv Med Oncol 3(1) 27_33

    Google Scholar 

  • Westerdahl J, Andren-Sandberg A, Ihse I (1993) Recurrence of exocrine pancreatic cancer—local or hepatic. Hepatogastroenterology 40:384–387

    PubMed  CAS  Google Scholar 

  • Wey JS, Fan F, Gray MJ et al (2005) Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 104:427–438

    Article  PubMed  CAS  Google Scholar 

  • Willett CG, Kozin SV, Duda DG et al (2006) Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol 33:S35–S40

    Article  PubMed  CAS  Google Scholar 

  • Willett CG, Lewandrowski K, Warshaw AL et al (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217:144–148

    CAS  Google Scholar 

  • Willett CG, Safran H, Abrams RA et al (2003) Clinical research in pancreatic cancer: the radiation therapy oncology group trials. Int J Radiat Oncol Biol Phys 56:31–37

    Article  PubMed  Google Scholar 

  • Xi M, Liu MZ, Deng XW, Zhang L, Huang XY, Liu H et al (2007) Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. Radiother Oncol 8:272–278

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiation Oncology Department, Centre Hospitalier Lyon Sud, Université Claude Bernard, EA 3738, Lyon, France

    F. Mornex, M. Hatime, S. Touch, B. Elmorabit, G. Pigne, C. Enachescu, O. Diaz & Y. Elkhoti

Authors
  1. F. Mornex
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Hatime
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Touch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Elmorabit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Pigne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Enachescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Diaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y. Elkhoti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Mornex .

Editor information

Editors and Affiliations

  1. Tumor- und Brustzentrum ZeTuP AG, Rorschacherstr. 150, St. Gallen, 9006, Switzerland

    Florian Otto

  2. Rheinstr. 2, Saarbrücken, 66113, Germany

    Manfred P. Lutz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Mornex, F. et al. (2012). Radiotherapy of the Pancreas: State of the Art in 2012. In: Otto, F., Lutz, M. (eds) Early Gastrointestinal Cancers. Recent Results in Cancer Research, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31629-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-31629-6_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-31628-9

  • Online ISBN: 978-3-642-31629-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation